Quantitative Parameters of Intravoxel Incoherent Movement Imaging and Dynamic Contrast Enhancement MRI for the Prediction of HER2-Zero, -Low, and -Positive Breast Cancers

Acad Radiol. 2024 Nov 25:S1076-6332(24)00857-2. doi: 10.1016/j.acra.2024.11.011. Online ahead of print.

Abstract

Rationale and objectives: To explore the predictive value of quantitative parameters from intravoxel incoherent movement (IVIM) imging and dynamic contrast enhancement MRI (DCE-MRI) for HER2 expression in breast cancer.

Materials and methods: This retrospective study included 167 women with breast cancer who underwent MRI from December 2019 to December 2023, categorized into 48 HER2-positive, 78 HER2-low and 41 HER2-zero cancers. All patients underwent IVIM imaging and DCE-MRI. Statistical analyses, including one-way ANOVA, Kruskal-Wallis test and χ2 test, were employed to compare clinical data, MRI features, and MRI quantitative parameters including standard ADC(ADC), pure diffusion coefficient(D), perfusion-related diffusion coefficient(D*), perfusion fraction(f), volume transfer constant(Ktrans), extravascular extracellular interstitial volume ratio(Ve) and rate constant(Kep) between the three groups. Multivariable logistic regression was used to identify independent predictors for distinguishing HER2 expressions. The diagnostic efficacy of significant IVIM and DCE parameters for different HER2 expressions was analyzed using receiver operator characteristic (ROC) curves.

Results: Peritumoral edema, histological grade and Kep achieved an AUC of 0.86(95%CI:0.78,0.91) in distinguishing HER2-positive tumors from HER2-low expressing tumors and were independent predictors for differentiating these two groups. Among HER2-positive and -zero breast cancers, the combined model of D*, Ktrans and Kep had an AUC of 0.74(95%CI:0.63,0.82) for the prediction of HER2-positive versus HER2-zero cancers, and its prediction efficiency was not improved compared with that of a single parameter(P > .05).

Conclusion: Quantitative parameters from intravoxel incoherent movement imaging and dynamic contrast enhancement MRI can predict different HER2 expressions in breast cancer from different perspectives, with implications for therapy.

Keywords: Brest cancer; Dynamic contrast-enhanced MRI; Human epidermal growth factor receptor 2; Intravoxel Incoherent Movement Imging; Magnetic resonance imaging.